AEON Biopharma Reports Biosimilar Progress, Secures $3.5M AEON Biopharma on Mar 30, 2026 announced completion of analytical comparability work and a $3.5M financing, targeting an IND filing in Q4 2026 (Investing.com, Mar 30, 2026).

AEON Biopharma Reports Biosimilar Progress, Secures $3.5M: AEON Biopharma on Mar 30, 2026 announced completion of analytical comparability work and a $3.5M financing, targeting an IND filing in Q4… 👈 Read full analysis #Biopharma #Biosimilars #HealthcareInvestment #INDFilings #PharmaceuticalIndustry